NCT04339803

Brief Summary

This study will investigate the maximum dose per day of using mirror therapy for ankle exercise after stroke. The design is a 3+3 rule based, dose- finding study. Each cohort will consist of three participants. The first cohort will be assigned to do a dose of 15 minutes each day for two weeks. The second and subsequent cohorts will exercise at target dose set accordance to the nine preset rules and the modified Fibonacci sequence (mFBS).The study will continue until the stopping rule is triggered. The last dose tested will be identified as the maximum tolerable dose per day.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at P25-P50 for early_phase_1 stroke

Timeline
Completed

Started Apr 2019

Typical duration for early_phase_1 stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 23, 2019

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

March 23, 2020

Completed
17 days until next milestone

First Posted

Study publicly available on registry

April 9, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 9, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 9, 2021

Completed
Last Updated

November 8, 2021

Status Verified

November 1, 2021

Enrollment Period

2.3 years

First QC Date

March 23, 2020

Last Update Submit

November 5, 2021

Conditions

Keywords

Mirror therapyRehabilitationLower limbMotor recovery

Outcome Measures

Primary Outcomes (1)

  • Changes in the Motricity Index

    Baseline, 2 weeks.

Secondary Outcomes (3)

  • Changes in the Symmetry

    Baseline, 2 weeks

  • Changes in the Neural excitability

    Baseline, 2 weeks

  • changes in the Transcranial magnetic stimulation (TMS)

    Baseline, 2 weeks

Study Arms (1)

mirror therapy

EXPERIMENTAL

lower limb mirror therapy using ankle exercise

Other: rehabilitation intervention

Interventions

we use lower limb mirror therapy after stroke for two weeks

mirror therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants have had a stroke for six weeks or more before recruitment to this study, and are discharged from NHS statutory stroke rehabilitation.
  • Participants will be at least 18 years of age
  • Able to produce some voluntary contraction of paretic ankle ( motricity index between 9 and 19).
  • Ability to understand and follow simple verbal instructions (one-stage commands), i.e. sufficient communication, orientation, and memory to participate in mirror therapy ankle exercise.
  • Participants will have had no lower limb injury in the last six months and were able to walk independently indoors before the index stroke.

You may not qualify if:

  • Foot or ankle contracture that prevents 50% of the passive range of motion.
  • Any condition that can be exaggerated by performing the therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sarah Bajuaifer

Norwich, NR4 7TJ, United Kingdom

Location

Related Publications (1)

  • Bajuaifer S, Grey MJ, Hancock NJ, Chandler E, Pomeroy VM. Maximum tolerable daily dose of mirror movement therapy ankle exercises after stroke: an early phase dose screening study. Physiotherapy. 2024 Mar;122:30-39. doi: 10.1016/j.physio.2023.10.007. Epub 2023 Nov 4.

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Valerie Pomeroy, Professor

    School of Health Sciences, University of East Anglia

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 23, 2020

First Posted

April 9, 2020

Study Start

April 23, 2019

Primary Completion

August 9, 2021

Study Completion

August 9, 2021

Last Updated

November 8, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Participant data only will be shared with the research team

Locations